Aug 4, 2016 – CARY, IL, USA July 29, 2016 — Sage Products announced today it is voluntarily initiating a nationwide recall of one lot of Comfort Shield Barrier Cream Cloths to the distributor and health care facility/user level. The recall is being initiated due to product contamination with the bacteria, Burkholderia cepacia.
Topical administration of a product with B. cepacia may cause serious infections in patients whose bodies cannot fight disease or in hospitalized patients, as well as certain other patient groups. These infections could be life-threatening. To date, no adverse events have been reported associated with the recalled products, which were distributed to distributors and healthcare facilities in the United States.
The product, Comfort Shield Barrier Cream Cloths is a non-sterile, topical skin protectant used to treat and prevent moisture associated skin irritation caused by urine and/or stool exposure. The package contains three, single-use, disposable cloths. This recall affects the following lot of Comfort Shield Barrier Cream Cloths.
Sage Products notified its distributors and health care facilities by letter, and they were provided instructions to discontinue use and return product to Sage Products. The affected lot was distributed to customers between March 31, 2016 and June 8, 2016.
Customers who received affected products should discontinue use of the affected products and return them to Sage Products for credit by contacting Sage Products customer service at 1-800-421-6556, Monday through Friday, between the hours of 8:00 a.m. to 5:00 p.m., Central Time
Customers with questions regarding this recall, or requiring replacement product, can call Sage Products customer service at 1-800-421-6556, Monday through Friday, between the hours of 8:00 a.m. to 5:00 p.m., Central Time. Patients should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
Any adverse reactions or quality problems experienced with the use of this product may be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
•Complete and submit the report online: www.fda.gov/medwatch/report.htm
•Regular mail or fax: download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178